MCRB - Seres Therapeutics Inc
IEX Last Trade
0.7976
0.008 0.953%
Share volume: 1,241,987
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.79
0.01
0.96%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-02 | 2023-03-07 | 2023-05-09 | 2023-08-08 | 2023-11-02 | 2024-03-05 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 273.196 M | 311.868 M | 348.784 M | 270.194 M | 406.387 M | 367.699 M | 358.600 M | 341.262 M | |
| Current Assets | 209.580 M | 247.513 M | 194.764 M | 116.081 M | 251.238 M | 214.394 M | 175.410 M | 165.181 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 5.340 M | 18.525 M | 29.647 M | 41.973 M | |
| Other Current Assets | 13.785 M | 14.510 M | 13.423 M | 9.537 M | 16.378 M | 25.957 M | 9.124 M | 12.024 M | |
| Short Term Investments | 13.785 M | 14.510 M | 13.423 M | 9.537 M | 16.378 M | 25.957 M | 9.124 M | 12.024 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 8.674 M | 0.000 | |
| Current Cash | 195.795 M | 233.003 M | 181.341 M | 106.544 M | 229.520 M | 169.912 M | 127.965 M | 111.184 M | |
| Total Non-current Assets | 63.616 M | 64.355 M | 154.020 M | 154.113 M | 155.149 M | 153.305 M | 183.190 M | 176.081 M | |
| Property Plant Equipment | 19.520 M | 19.484 M | 22.985 M | 24.306 M | 24.026 M | 23.566 M | 22.457 M | 19.115 M | |
| Other Assets | 9.509 M | 11.538 M | 10.465 M | 11.307 M | 11.254 M | 12.048 M | 41.354 M | 41.466 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 273.196 M | 311.868 M | 348.784 M | 270.194 M | 406.387 M | 367.699 M | 358.600 M | 341.262 M | |
| Total liabilities | 250.138 M | 244.283 M | 338.001 M | 318.065 M | 383.773 M | 382.822 M | 403.456 M | 401.000 M | |
| Total current liabilities | 89.037 M | 81.819 M | 85.596 M | 63.818 M | 77.898 M | 79.225 M | 98.659 M | 98.478 M | |
| Accounts Payable | 13.992 M | 10.449 M | 17.440 M | 12.297 M | 12.922 M | 8.958 M | 3.641 M | 5.219 M | |
| Other liabilities | 90.953 M | 93.757 M | 93.872 M | 96.321 M | 98.427 M | 97.599 M | 97.538 M | 97.172 M | |
| Current long term debt | 0.000 | 0.000 | 456.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 50.632 M | 50.857 M | 50.591 M | 51.234 M | 100.742 M | 101.135 M | 101.544 M | 102.009 M | |
| Other liabilities | 90.953 M | 93.757 M | 93.872 M | 96.321 M | 98.427 M | 97.599 M | 97.538 M | 97.172 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 23.058 M | 67.585 M | 10.783 M | -47.871 M | 22.614 M | -15.123 M | -44.856 M | -59.738 M | |
| Common stock | 92.255 M | 122.527 M | 125.361 M | 125.863 M | 127.713 M | 128.290 M | 130.147 M | 146.102 M | |
| Retained earnings | -735.713 M | -795.715 M | -864.511 M | -935.685 M | -889.133 M | -936.987 M | -978.235 M | -1.018 B |